View Document Preview and Link Open Document File Size: 333,65 KB Share Result on Facebook
City San Francisco / Ngom / Kampala / Fresno / Buley / / Company Jepson / Crompton / Meda / Bancone G / Hubbard AE / Fleming / IgG / LG / Lang 2009 Improved / Ogden / Fry AE / Bunn HF / Lehman / Google / Boyo AE / Spiegel / Jeffreys AE / Motulsky AG / Cox / BioMed Central Ltd. / Creative Commons / / Continent Africa / / Country Senegal / Kenya / Uganda / Burkina Faso / Gabon / Sudan / Zimbabwe / Congo / Mali / Gambia / United States / Nigeria / Ghana / / / Event FDA Phase / Product Issues / / Facility University of California / National Institute of Allergy / University of California Berkeley-University / / IndustryTerm chemical difference / treatment of sickle cell disease / online submission / / MedicalCondition Bryan Greenhouse3* Abstract Sickle cell trait / natural malarial infections / severe falciparum malaria / sickle cell anemia / local inflammation / subtertian malareal infection / fatal malaria / high-parasitemia and cerebral malaria / severe and fatal Plasmodium falciparum malaria / Glucose6-phosphate-dehydrogenase deficiency / P falciparum malaria / Thalassemia / altered disease / red blood cell enzyme deficiency / severe disease / thalassemias / malaria / uncomplicated malaria / Plasmodium falciparum infections / clinical Plasmodium falciparum malaria / Protection Background Malaria / associated inflammation / G6PD deficiency / acute malarial infection / Plasmodium berghei infection / sickle cell trait Sickle haemoglobin / diseases / dehydrogenase deficiency / annexin-A7 deficiency / P. falciparum malaria / infection / homozygous sickle cell disease / childhood diseases / Malaria Research / parasite strains causing blood stream infections / parasitaemia and less clinical malaria / both severe and uncomplicated malaria / both uncomplicated and severe malaria / Reduced cytoadherence Cholera / beta-thalassemia trait / submicroscopic P. falciparum infection / falciparum malaria / Human cerebral malaria / decreased inflammation / cerebral malaria / MS / infections / high malaria / Hemoglobinopathies / hemolytic anemia / uncomplicated falciparum malaria / Plasmodium infection / disease / Plasmodium falciparum malaria / uncomplicated disease / symptomatic disease / Chronic low levels / high parasitemias / Cholera R / human malaria / symptomatic malaria / severe malaria / vivax malaria / Plasmodium falciparum infection / predominantly asymptomatic Plasmodium infections / sickle cell disease / sickle cell trait / inflammation / anemia / pathogenic host inflammatory responses / malaria Lauren Gong1 / / MedicalTreatment immunosuppression / / Organization Doris Duke Charitable Foundation / University of California / National Institute of Allergy and Infectious Diseases / African Union / University of California San Francisco Joint Medical Program / 2Yale University / / Person Abu Zeid / Ann Trop Med / / Position Soares MP / Doris Duke Clinical Scientist Development Award / author / King / Henson PM / medical officer / Alpers MP / / Product DV / cell-mediated immunity / erythrocytes / CD36 / HO-1 / cytoadherence / Plasmodium-infected / / ProvinceOrState British Columbia / California / Papua / / PublishedMedium PLoS One / / RadioStation Dondorp AM / Ndungu FM / Cathelineau AM / / Region West Africa / Northern Rhodesia / South Western Nigeria / western Kenya / northern Ghana / sub-Saharan Africa / / Technology genotyping / human genome / DNA Chip / genotype / alpha / antibodies / / URL http / SocialTag 
Baseline results of the first malaria indicator survey in Iran at the health facility level